News Articles Tagged: EGFR-AKT-STAT Pathway

The Role of Benzo[a]pyrene-1,6-dione in Cancer Research: A Deeper Look

Explore the scientific significance of Benzo[a]pyrene-1,6-dione (CAS 3067-13-8) in understanding cancer mechanisms, including its interaction with EGFR pathways and its classification as a mutagen and carcinogen.

Demystifying Doxorubicin: Mechanisms of Cell Death and Targeted Intervention

A deep dive into how doxorubicin induces cancer cell death through DNA damage and metabolic pathway modulation, with a focus on actionable targets like the EGFR/Src pathway.

EGFR/Src Pathway Inhibition: A Key to Doxorubicin's Cancer-Fighting Mechanism

Delve into the scientific findings that link doxorubicin's anti-cancer effects to the inactivation of the EGFR/Src pathway and the subsequent impact on cholesterol metabolism.

The Cholesterol Connection: How Managing Lipids Boosts Doxorubicin's Anti-Cancer Power

Explore the groundbreaking research linking cholesterol levels to doxorubicin's effectiveness in cancer treatment. Learn how understanding the EGFR/Src pathway can lead to improved patient outcomes.